More targeted R&D investment towards driving UK growth and jobs unveiled by Technology Secretary
UKRI will deploy significant taxpayer backing to support government priorities, investing billions in UK expertise and innovation for growth and renewal.
- The UK’s public research funding body will deploy a significant portion of £38.6 billion in taxpayer backing to support government priorities, investing billions in UK expertise and innovation for growth and national renewal, Science and Technology Secretary Liz Kendall says
- UKRI to invest £8 billion for specific government priorities and £7 billion for innovative company growth, to build and keep titans of future industries like quantum based in UK, building strong foundations for our economy
- Part of a package of announcements aimed at boosting funding and the in-flow of international talent into high-growth sectors of the future
Record public research funding will be explicitly directed towards supporting promising scale-ups, turbocharging economic growth and job opportunities through our Modern Industrial Strategy, and improving lives, as part of a shake-up of public R&D announced today. The move reinforces the government’s push for national renewal, a Britain built for all, and a fairer economy that works for and rewards working people - work which will be further cemented through announcements at the Budget, later this week.
Addressing research funders and major business leaders from the UK and beyond, the Science and Technology Secretary Liz Kendall said today (Monday 24 November) that public R&D funding had for too long been spread thinly across multiple priorities and projects and now was time for ‘doing fewer things, better’. She outlined a ‘no-compromise’ approach that prioritises funding for the companies with the highest potential to grow into industry titans and into the sectors where the UK already retains a competitive advantage. Setting these priorities clearly, will support the national effort to build strong foundations for our economy and secure our country’s future.
UKRI is the country’s largest public research funder, giving it a central role in ensuring public money is invested in ambitious, pioneering research that will benefit the whole of the UK and provide a clear return on investment for hardworking taxpayers.
Addressing the UKRI Growth Summit in London, Science and Technology Secretary Liz Kendall said:
Scientific research and development is fundamental to building a better Britain: from new treatments for cancer, to breakthroughs in clean, affordable energy.
There is no route to stronger growth in this country, no answer to how we pay our way, or compete with the rest of the world, without science, technology and innovation leading front and centre. But we must be smarter about what we prioritise, for these efforts to succeed.
That is what today is all about. And by increasing funding for critical technologies like AI and engineering biology where the UK already excels, we can go even further.
£9 billion of UKRI’s record £38.6 billion settlement will go towards backing the fields of research in which the UK is among the strongest in the world, like AI and quantum, which could deliver breakthroughs in healthcare or pioneering cybersecurity tech to keep our country safe from threats. Funding for engineering biology will increase nearly three-fold, to £644 million, while funding for AI will more than double to £1.6 billion.
The International Monetary Fund (IMF) estimates that breakthroughs in AI alone could boost productivity by as much as 1.5 percentage points a year, which could be worth up to an average £47 billion to the UK each year over a decade. Quantum computing meanwhile could add over £11 billion to the UK’s GDP by 2045.
£8 billion will be allocated to funding research into the government’s priorities, including the Strategy’s priority areas and others like climate resilience and flood defence.
While another £7 billion will specifically fund innovative company growth to unlock the next generation of UK industry titans, building on the example set by:
- Cambridge-based Paragraf, which has raised around $140 million since it was founded in 2018 as a leader of graphene, powering products like electric cars and medical scanners more efficiently
- IFast, a diagnostics firm, working to detect antibiotic resistance much faster than traditional methods.
- Ceres Power, a clean energy company behind cutting edge fuel cell technology for hydrogen production, employing around 600 people and with a market capitalisation of over £700 million.
The third ‘bucket’ will see £14 billion going towards curiosity-driven research, which has been at the heart of great discoveries for generations – from the internet to medical breakthroughs that can treat a range of genetic diseases.
Universities will be key beneficiaries from UKRI’s record funding for R&D. Their core block grant and commercialisation funding from DSIT will grow in line with expected inflation over the Spending Review period.
Attracting top science and research talent to the UK, especially in the 8 key sectors of the Modern Industrial Strategy, is essential for achieving cutting-edge breakthroughs that economic growth, jobs, and entire new industries will be founded upon. Today the Science Secretary has also revealed the progress being made in those efforts – with the first 4 world-leading researchers relocating to the UK through the £54 million Global Talent Fund. These lead researchers are expected to also bring up to 10 individuals to support their research projects from abroad.
These leading researchers will be based across the country, and are spearheading work that could transform our health and wealth, ranging from efforts in neurobiology – which could give new insights into Alzheimer’s - to better ways of tackling the pests and diseases that could cost the global agriculture industry over £400 billion in losses every year if left unchecked.
This comes alongside additional leading scientists and academics being welcomed to the UK via other DSIT funded flagship talent and grant schemes delivered through UKRI and the UK’s 4 National Academies.
Alongside this transformative reform to R&D funding and work bringing in the best international talent, the government is also today announcing a raft of further announcements that will help support our R&D sector to turbocharge economic growth in the UK:
- Launching the competition to find the next Chair of UKRI’s Board, as Sir Andrew MacKenzie’s term concludes after adeptly leading the UKRI Board since 2021. We are seeking a leader committed to protecting and growing curiosity-driven research, addressing government priorities and tackling the UK’s biggest challenges. They will also play a key role in enabling R&D-intensive companies to start up, scale up and stay in the UK while helping to leverage the private sector backing that can take discoveries to the next level
- Setting UK researchers 2 ambitious challenges as part of our R&D Missions Accelerator Programme, backed by £4 million in the first year, on industrialising and digitalising construction and developing the infrastructure for our creative content exchange
- Launching the latest round of Innovate UK’s Women in Innovation Awards, with £4.5 million available for up to 60 women – building on findings showing that if men and women started and scaled businesses at the same rate, this could add up to £250 billion to the UK economy
- Trebling the government’s investment in the UK’s world-leading Metascience Unit to £49 million. The unit supports research into how we can increase the impact and efficiency of investment in science
UKRI CEO, Professor Sir Ian Chapman said:
The record investment in R&D shows government’s commitment to putting UK research and innovation at the forefront of our national success. At UKRI, our mission is clear: to advance knowledge, improve lives, and drive growth. We will invest strategically in areas where the UK can achieve a significant market share globally. Research and innovation must be central to boosting the UK’s economy and delivering real improvements to people’s lives and livelihoods.
Notes to editors
Universities will see their core flexible research and commercialisation funding grow in line with expected inflation over the next 3 academic years.
Applications for Innovate UK’s Women in Innovation Awards are open until 4 February 2026.
One of the Metascience Unit’s early successes has been the trial of Distributed Peer Review – a novel method of assessing research proposals in which applicants themselves participate in the review process. UKRI will now expand the use of Distributed Peer Review across the organisation, enabling researchers from all disciplines to access funding more quickly and experience fewer delays between proposal development and project initiation. And we are launching a new £6 million grant opportunity for UK-led metascience projects.
Global Talent Fund details
Attracting international talent is the catalyst for creating British jobs, boosting investment, and increasing productivity – just what our economy needs. The £54 million Global Talent Fund is enabling leading scientists and their teams to relocate and thrive in the UK. The Fund is designed to attract a total of 60-80 individuals in top research teams to the UK, working in the 8 high priority sectors critical to our modern Industrial Strategy like life sciences and digital technologies.
This work is supported by the Global Talent Taskforce, which is driving efforts to ensure the UK remains a world leader in attracting and retaining exceptional talent. By bringing the very best minds to the UK, working in fields that will be critical to our health, business, and everyday life, we can pave the way for the products, jobs and even industries that define tomorrow’s economy, to be made and grow in Britain.
The Fund is being delivered by 12 of the UK’s leading universities and research institutions.
Talent recruitment through the Fund is already underway, with the following researchers and academics having joined, or being set to join, institutions in the UK:
-
Professor Baljit Khakh, joining Cardiff University as the new Director of UK Dementia Research Institute, from UCLA, United States. His exceptional work in the fields of neurobiology and neurodegeneration have seen him honoured with the H.W Magoun Distinguished Lectureship, the 134th UCLA Faculty Research Lecture, NIH Director’s Pioneer Award and election to the Fellowship of the Royal Society (FRS) - the highest accolade in UK science.
-
Professor Armin Raznahan, who is being appointed to the W. A. Handley Chair in Psychiatry at the University of Oxford. Professor Raznahan is a child and adolescent psychiatrist, and will be joining Oxford’s Merton College from his current role at the US National Institute of Mental Health Intramural Research Program (NIMH IRP). His work is focused on improving outcomes for young people with mental health problems.
-
Dr Hassan Salem joining the John Innes Centre, from the Max Planck Institute for Biology, Germany. Dr Salem’s research focuses on the relationship between plants an insects, including pests and the diseases they carry – a critical area of work for food security. Crop losses caused by plant diseases and pests could cost the global economy over £400 billion a year if left unchecked.
-
Dr Sven Truckenbrodt, who has joined the MRC Laboratory of Molecular Biology from a research not-for-profit in California, United States. Sven is pioneering work on ‘molecular connectomics’: a new way of mapping how the brain works – which could change how we understand mental health problems. In his career to date he has invented new ways of mapping and tracking brain activity. The Global Talent Fund has allowed Sven to obtain highly specialised microscopes at the cutting edge of available technology, perfectly tailored to his research needs.
The Global Talent Fund, administered by UKRI, is just one part of over £115 million funding that is being dedicated to attracting the very best scientific and research talent to the UK. This includes the expanded Encode: AI for Science Fellowships and the Turing AI Fellowships, which is embedding world-class AI researchers into UK labs, ensuring the UK remains a global hub for cutting-edge research and innovation.
It sits alongside additional DSIT funded flagship talent and grant schemes open to international research talent delivered through UKRI and the UK’s 4 prestigious National Academies. For example, the Royal Society’s Newton International Fellowships and the British Academy’s International Fellowships which are both aimed at attracting outstanding international early-career researchers to the UK.
Today, the Medical Research Council (MRC) is announcing additional funding of up to £8.5 million to expand its ‘early independence’ Career Development Award (CDA) and Clinical Scientist Fellowship (CSF) schemes, making it easier for international researchers to build careers in the UK.
Just last week, the Academy of Medical Sciences announced their latest 3 Professorship Awards, funding top-level researchers working on child mental health, heart disease and cancer to continue their work in the UK.
The Royal Society also recently announced a cohort of exceptional researchers awarded early career fellowships open to domestic and international talent and worth more than £83 million. These early career schemes are supported by DSIT and include the University Research Fellowships, Dorothy Hodgkin Fellowships and Newton International Fellowships.
The Royal Society recently announced its first awards for the Faraday Discovery Fellowships and the Royal Academy of Engineering are also expected to announce their first awards for the Green Future Fellowships in due course – both schemes are open to international talent, and have launched additional Accelerated International Application routes for exceptional non-UK-based researchers.
DSIT media enquiries
Email press@dsit.gov.uk
Monday to Friday, 8:30am to 6pm 020 7215 3000